Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials

Calibrated dynamic borrowing using capping priors

(2022) Sharon X. Ling et al.   Journal of Biopharmaceutical Statistics

Borrowing from supplemental sources to estimate causal effects from a primary data source

(2021) Jeffrey A. Boatman et al.   STATISTICS IN MEDICINE

Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data

(2020) Wei-Chen Chen et al.   Journal of Biopharmaceutical Statistics

Extending inferences from a randomized trial to a new target population

(2020) Issa J. Dahabreh et al.   STATISTICS IN MEDICINE

Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies

(2019) Chenguang Wang et al.   Journal of Biopharmaceutical Statistics

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

(2019) Richard T Davey et al.   Lancet Respiratory Medicine

Dynamic borrowing in the presence of treatment effect heterogeneity

(2019) Ales Kotalik et al.   BIOSTATISTICS

A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies

(2018) Alexander M. Kaizer et al.   BIOMETRICS

Randomised controlled trials - the gold standard for effectiveness research

(2018) Eduardo Hariton et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Use of historical control data for assessing treatment effects in clinical trials

(2013) Kert Viele et al.   PHARMACEUTICAL STATISTICS

Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials

(2011) Brian P. Hobbs et al.   BIOMETRICS

The cost of drug development: A systematic review

(2011) Steve Morgan et al.   HEALTH POLICY

Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: The INSIGHT FLU 002 and FLU 003 studies

(2011) Dominic E. Dwyer   VACCINE